Lexicon Pharmaceuticals
LXRX
#6851
Rank
ยฃ0.52 B
Marketcap
ยฃ1.18
Share price
-7.49%
Change (1 day)
6.28%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -ยฃ45.8 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ41.46 Million. In 2025 the company made an earning of -ยฃ38.45 Million, an increase over its 2024 earnings that were of -ยฃ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ45.8 Million19.13%
2025 -ยฃ38.45 Million-74.88%
2024 -ยฃ0.16 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ77.85 Million16.16%
2021 -ยฃ67.02 Million49.82%
2020 -ยฃ44.73 Million-147.19%
2019 ยฃ94.78 M-203.42%
2018 -ยฃ91.66 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.58 Million-95.33%
2014 -ยฃ76.65 Million-3.61%
2013 -ยฃ79.52 Million-5.52%
2012 -ยฃ84.17 Million-4.17%
2011 -ยฃ87.83 Million15.5%
2010 -ยฃ76.05 Million8.36%
2009 -ยฃ70.18 Million-4.81%
2008 -ยฃ73.72 Million28.79%
2007 -ยฃ57.24 Million35.71%
2006 -ยฃ42.18 Million52.91%
2005 -ยฃ27.59 Million-23.89%
2004 -ยฃ36.24 Million-24.19%
2003 -ยฃ47.8 Million-0.48%
2002 -ยฃ48.03 Million44.12%
2001 -ยฃ33.33 Million23.01%
2000 -ยฃ27.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ6.03 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.85 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ4.34 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.35 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ46.51 M-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ60.62 M-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.75 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ33.34 M-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ12.62 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA